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Abstract
Background: The aim of this study was to compare the plan quality of magnetic-resonance image-based intensity
modulated radiation therapy (MRI-based-IMRT) with the MRIdian Linac system to that of volumetric modulated arc
therapy (VMAT) with the TrueBeam STx system for lung stereotactic ablative radiotherapy (SABR).
Methods: A total of 22 patients with tumors located in the lower lobe were retrospectively selected for the study.
For each patient, both the MRI-based-IMRT and VMAT plans were generated using an identical CT image set and
identical structures with the exception of the planning target volume (PTV). The PTVs of the MRI-based-IMRT were
generated by adding an isotropic margin of 3 mm from the gross tumor volume, whereas those of VMAT were
generated by adding an isotropic margin of 5 mm from the internal target volume. For both the MRI-based-IMRT
and VMAT, the prescription doses to the PTVs were 60 Gy in four fractions.
Results: The average PTV volume of the MRI-based-IMRT was approximately 4-times smaller than that of VMAT
(p < 0.001). The maximum dose to the bronchi for the MRI-based-IMRT was smaller than that for the VMAT (20.4 Gy
versus 24.2 Gy, p < 0.001). In addition, V40Gy of the rib for the MRI-based-IMRT was smaller than that for the VMAT
(1.8 cm3 versus 7.7 cm3, p = 0.008). However, the maximum doses to the skin and spinal cord for the MRI-based-IMRT
(33.0 Gy and 14.5 Gy, respectively) were larger than those for the VMAT (27.8 Gy and 11.0 Gy, respectively) showing
p values of less than 0.02. For the ipsilateral lung, the mean dose, V20Gy, V10Gy, and V5Gy for the MRI-based-IMRT were
smaller than those for the VMAT (all with p < 0.05). For the contralateral lung, V5Gy, V10Gy, D1500cc, and D1000cc for the
MRI-based-IMRT were larger than those for the VMAT (all with p < 0.05). The mean dose and V50% of the whole body
for the MRI-based-IMRT were smaller than those for the VMAT (0.9 Gy versus 1.2 Gy, and 78.7 cm3 versus 103.5 cm3,
respectively, all at p < 0.001).
Conclusions: The MRI-based-IMRT using the MRIdian Linac system could reduce doses to bronchi, rib, ipsilateral lung,
and whole body compared to VMAT for lung SABR when the tumor was located in the lower lobe.
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Background
Since the release of the MRIdian® Linac system (ViewRay
Inc., Oakwood Village, OH), linear accelerators with a
magnetic resonance imaging system (MR-linac) have be-
come clinically available. The MRIdian Linac system can
generate 6 MV flattening filter free (FFF) beams with a
maximum dose rate of 6 Gy/min using an S-band standing
wave linear accelerator (linac) [1]. Therefore, the MRIdian
Linac system generates treatment beams with higher
penetrability and smaller penumbrae than those of the
ViewRay® system (ViewRay Inc., Oakwood Village, OH),
which is a previous model for magnetic resonance image-
guided radiation therapy (MR-IGRT) that uses Co-60 ra-
dioisotopes to generate treatment beams [2, 3]. Although
the MRIdian Linac system is equipped with a linac, 3D
volumetric and 2D planar magnetic resonance images
(MRI) can be acquired using a 0.35 T magnetic field, simi-
lar with the ViewRay system [1]. The mutual interference
that occurs between the linac and MR imaging systems of
the MRIdian Linac system were eliminated using patented
technology from ViewRay, Inc. [1]. In addition to the suc-
cessful integration of the linac and MR imaging systems, a
notable feature of the MRIdian Linac system is a double-
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stacked and double-focused multi-leaf collimator (MLC)
system that can project field sizes of 0.2 cm × 0.4 cm to
27.4 cm× 24.1 cm at the isoplane located 90 cm from the
source [1]. Using this MLC system, the MRIdian Linac
system can conduct step-and-shoot intensity modulated
radiation therapy (IMRT) with fluences at a finer reso-
lution than those of the ViewRay system, thereby poten-
tially improving the quality of the treatment plan [4, 5].
One of the indications of MR-IGRT is lung cancer owing
to the substantial respiratory motions of the lung tumors
[6]. Because the MR-IGRT technique can be used in re-
spiratory gated radiation therapy based on the application
of real-time cine planar MR images during treatment with-
out additional imaging doses, the margins of the lung target
volumes can be significantly reduced, which results in sub-
stantially smaller doses to normal tissue [2]. This advantage
can be maximized in stereotactic ablative radiotherapy
(SABR) for lung cancer because the fractional doses of lung
SABR are much larger than those of conventional fraction-
ated radiation therapy and should be delivered to patients
accurately for lung SABR [7]. Several previous studies have
compared the dose distributions of MR-IGRT using the
ViewRay system to those of linac-based IMRT or linac-
based volumetric modulated arc therapy (VMAT) and re-
ported that the plan quality of the ViewRay system is clinic-
ally acceptable but no better than that of linac-based IMRT
and VMAT owing to the inferior beam quality of the Co-60
source and the large MLC leaf width of the ViewRay system
[2, 3, 8–11]. Specifically for lung target volumes of smaller
than 10 cm3, the plan quality of internal target volume
(ITV) based VMAT is statistically significantly better than
that of gross tumor volume (GTV) based IMRT using the
ViewRay system despite the margin reduction capability of
the ViewRay system [2].
Because the MRIdian Linac system overcomes the disad-
vantages of the ViewRay system, including the poor charac-
teristics of the Co-60 source beams and the large MLC leaf
width, the plan quality of the MRIdian Linac system might
be better than that of a conventional IMRT or VMAT by
virtue of its margin reduction capability. In contrast, the
MRIdian Linac system can only generate coplanar step-
and-shoot IMRT plans whose plan quality might be inferior
to that of VMAT. It is therefore unclear whether the lung
SABR plan quality of the MRIdian Lianc system is better
than that of VMAT. Thus, in the present study, we com-
pared lung SABR IMRT plans using the MRIdian Linac sys-
tem based on the GTV to those of VMAT plans using
TrueBeam STx™ (Varian Medical Systems, Palo Alto, CA)
based on the ITV for a total of 22 patients with lung cancer.
Methods
Patient selection and simulation
After receiving approval from the institutional review
board, a total of 22 patients treated for lung cancer with the
SABR VMAT technique were retrospectively selected for
this study. Because the respiratory motion of lung tumors
located in the lower lobe is known to be large, we selected
only patients with lung tumors located in the lower lobe
[6]. All patients were scanned using the Brilliance CT Big
Bore™ (Phillips, Cleveland, OH). Ten phase 4D CT images
were acquired using the Real-time Position Management™
(RPM, Varian Medical Systems, Palo Alto, CA) system for
each patient to define the ITV for VMAT planning. The
slice thickness of the CT images was 2mm. When acquir-
ing the CT images, all patients were immobilized using the
Body Pro-Lok™ (CIVICO, Orange City, IA) system to re-
duce the respiratory motion of the lung tumors.
Treatment planning of VMAT using TrueBeam STx
The planning target volume (PTV) was defined by adding
an isotropic margin of 5mm from the ITV in the 80%
phase CT image set [7]. The prescription dose to the PTV
was 60Gy in four fractions for all patients. VMAT plans
were generated using a 6 MV FFF beam of TrueBeam STx
with a High-Definition 120 MLC™ (Varian Medical Sys-
tems, Palo Alto, CA). For the planning, the Eclipse™ system
(Varian Medical Systems, Palo Alto, CA) was used. To
minimize the doses to the contralateral lung, two coplanar
half arcs near the ipsilateral lung were used. One half arc
was rotated from 180° to 0°, whereas the other half arc was
rotated from 0° to 180°. All VMAT plans were optimized
using the progressive resolution optimizer (PRO3, ver. 13,
Varian Medical Systems, Palo Alto, CA). The dose-volume
constraints during optimization were set according to the
National Comprehensive Cancer Network Clinical Practice
Guidelines in Oncology (NCCN Guidelines®, National
Comprehensive Cancer Network, Fort Washington, PA).
After optimization, the dose distributions were calculated
using the Acuros® XB algorithm (AXB, ver. 13, Varian Med-
ical Systems, Palo Alto, CA). The size of the dose calcula-
tion grid was 1mm, which is the finest resolution available
with the Eclipse system. After a dose calculation, all plans
were normalized to cover 95% of the PTV volume with
100% of the prescription dose.
Treatment planning of IMRT using MRIdian Linac system
Because this is a comparative planning study, CT images
identical to those of VMAT plans were used for the IMRT
planning with the MRIdian Linac system. The PTV was de-
fined by adding an isotropic margin of 3mm from the
GTV in the 80% phase CT image set because the MRIdian
Linac system is capable of anatomy-based gated radiation
therapy. The PTV was used as the gating window during
treatment, i.e., the treatment beams were delivered to a pa-
tient only when the GTV was inside the PTV. We added a
3-mm isotropic PTV margin empirically to consider the
daily variations in lung tumor movements of the patients.
The prescription dose to the PTV was identical to that of
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the VMAT plans, which was 60Gy in the four fractions.
Coplanar step-and-shoot IMRT plans were generated for
each patient with a 6 MV FFF photon beam of the MRIdian
Linac system using double-stacked and double-focused
MLCs. For the planning, the treatment planning system
(TPS) of the MRIdian Linac system which is the MRIdian
system (ViewRay Inc., Oakwood Village, OH) was used.
Eight or nine fields with various gantry angles were used
for each patient according to the tumor locations. The iso-
center was not moved laterally to avoid collisions between
the patient body and bore of the MRIdian Linac system. All
plans were optimized to meet the dose-volumetric con-
straints based on the same NCCN guidelines as used in the
VMAT planning. The sequencing number of segments was
set to 60 [1]. The IMRT efficiency was set to 3.00, which
determines the smoothness of the fluence map [1]. The
dose distributions were calculated using a dose calculation
grid of 2mm. When calculating the dose distributions, the
number of histories per cm2 was set to 25,000. After the
dose calculation, the calculated dose distributions were
imported from the MRIdian system to the Eclipse system
in order to calculate the dose-volumetric parameters and
dose volume histograms (DVHs) [12]. All plans were nor-
malized to cover 100% of the PTV volume with 99.99% of
the prescription dose because the PTV of the MRIdian
Linac system was generated without considering the in-
ternal target motion through respiration.
Evaluation of the treatment plans
For each plan, the total monitor unit (MU) and calculated
beam-on time in the TPS were acquired. For the IMRT
plans using the MRIdian Linac system, the average num-
ber of segments for each plan was acquired.
For the PTVs, the maximum, minimum, and mean
doses of the PTV and PTV volumes were calculated. The
minimum doses to 2% volume of the PTV (D2%), D5%,
D95%, and D98% were also calculated. The homogeneity
index (HI) was calculated as follows [13].
Homogeneity index HIð Þ ¼ D2%−D98%
mean dose
ð1Þ
For organs at risk (OARs), the maximum doses to the
bronchi, heart, rib, skin, and spinal cord were calculated.
The percent volume received at least 34.8 Gy (V34.8Gy) for
the bronchi, V30Gy for the esophagus, V34Gy for the heart,
V40Gy for the rib, V36Gy for the skin, and V26Gy for the
spinal cord were also calculated. For both the ipsilateral
and contralateral lungs, V20Gy, V10Gy, V5Gy, D1500cc, D1000cc,
and mean doses were calculated.
For whole body of a patient, mean dose to whole body
as well as the percent volume received at least 50% of the
prescription dose (V50%) were acquired.
A paired t-test was conducted to examine the statis-
tical significances of the differences in the parameters
between VMAT and IMRT using the MRIdian Linac sys-
tem. We regarded differences with p values of less than
0.05 as statistically significant.
Results
Differences in the plan parameters
The plan parameters of both VMAT and IMRT using an
MR-linac are shown in Table 1. The MU of the MRI-based
IMRT was twice that of VMAT on average (8373 MU for
MRI-based IMRT versus 4173 MU for VMAT, p < 0.001).
The calculated beam-on time of the MRI-based IMRT was
approximately 4-times larger than that of VMAT on aver-
age (18.4min for MRI-based IMRT versus 4.8min for
VMAT, p < 0.001).
Dose-volumetric parameters of PTV
The dose-volumetric parameters of the PTVs of both the
VMAT and MRI-based IMRT plans are shown in Table 2.
The dose distributions of VMAT and MRI-based IMRT for
the representative patients are shown in Fig. 1. The DVHs
of the representative patients are shown in Fig. 2.
The PTV volume of the MRI-based IMRT is approxi-
mately 4-times smaller than that of VMAT on average
(p < 0.001). The average values of D98%, D95%, and the
minimum dose of MRI-based IMRT were larger than
those of VMAT (all at p < 0.02) while the average values
of D5%, D2%, and the maximum dose of MRI-based
IMRT were smaller than those of VMAT (all at
p < 0.04). Therefore, HI indicates that the dose homo-
geneity inside the PTV volume of MRI-based IMRT was
better than that of VMAT (0.062 for MRI-based IMRT
versus 0.099 for VMAT, p < 0.001).
Dose-volumetric parameters of OARs
The dose-volumetric parameters of OARs are shown in
Table 3.
The maximum dose to the bronchi of MRI-based IMRT
was smaller than that of VMAT with a statistical signifi-
cance (20.4 Gy for MRI-based IMRT versus 24.2 Gy for
VMAT, p < 0.001). Both the maximum dose and V34Gy for
the heart were smaller in the MRI-based IMRT plans than
in the VMAT plans; however, the differences were not sta-
tistically significant (all at p > 0.05). The maximum dose
and V40Gy of the rib of MRI-based IMRT (43.0 Gy and 1.8
cm3, respectively) were smaller than those of VMAT
(47.2 Gy and 7.7 cm3, respectively) showing p values less
than 0.04, whereas the maximum doses to the skin and
spinal cord of MRI-based IMRT (33.0 and 14.5 Gy, re-
spectively) were larger than those of VMAT (27.8 and
11.0 Gy, respectively) showing p values of less than 0.02.
For the ipsilateral lung, the mean dose, V20Gy, V10Gy,
and V5Gy of the MRI-based IMRT were smaller than
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those of VMAT (all at p < 0.05), whereas D1500cc and
D1000cc of the MRI-based IMRT were larger than those
of VMAT (all at p < 0.02). For the contralateral lung,
V10Gy, V5Gy, D1500cc, and D1000cc of the MRI-based IMRT
were larger than those of VMAT with a statistical signifi-
cance (all at p < 0.05).
Dose-volumetric parameters of the whole body
The dose-volumetric parameters of the whole body are
shown in Table 3. The mean dose and V50% consistently
indicated that the irradiation of normal tissue of MRI-
based IMRT was lower than that of VMAT with a statis-
tical significance (all at p < 0.001).
Discussion
In the present study, we compared GTV-based IMRT plans
generated with the MR-linac to the ITV-based VMAT
plans for lung SABR. We retrospectively selected patients
with tumors located at lower lobes of the lungs, of which
the respiratory motions were large [6]. Therefore, the PTV
sizes of VMAT, including margins compensating for the re-
spiratory motion of the lung tumors, were much larger than
those of MRI-based IMRT (approximately 4.3-times larger),
which did not include the margins for respiratory motion.
By doing so, we were able to maximize the advantage of
MRI-based IMRT, which is internal anatomy-based gated
radiotherapy with real-time cine MR images. Despite the
smaller PTV sizes of MR-IGRT than those of conventional
ITV-based radiotherapy, a previous study demonstrated
that the lung SABR plan quality of the ViewRay system was
not better than that of VMAT owing to the poor character-
istics of Co-60 beams (large penumbrae and low penetrabil-
ity) and the large MLC width of the ViewRay system [2].
Specifically for target volumes of smaller than 10 cm3, no
benefits were observed when utilizing the ViewRay system
for lung SABR as compared to VMAT [2]. However, in the
present study, the MR-IGRT plans with the MR-linac dem-
onstrated superiority to the VMAT plans even for target
volumes of smaller than 10 cm3, showing less irradiation of
normal tissue with intermediate and high doses than in the
VMAT plans. As the results show, the volumes of body ir-
radiated by 50% of the prescription dose of MRI-based
IMRT were approximately 76% that of VMAT. In addition,
the MRI-based IMRT was generally able to reduce the
dose-volumetric parameters of the bronchi, rib, heart, and
ipsilateral lung as compared to VMAT. This better plan
quality was attributed to the margin reduction capability of
MRI-based IMRT combined with the improved photon
beam characteristics generated using the linac and small
leaf widths of the MLCs.
Although most of the clinically relevant dose-volumetric
parameters of MRI-based IMRT were better than those of
VMAT, this was not always the case. Regarding the
D1500cc and D1000cc of the ipsilateral lung, and all dose-
volumetric parameters of the contralateral lung examined
in this study, the maximum dose to the skin, and the max-
imum dose to the spinal cord from the MR-IGRT plans
were worse than those of the VMAT plans. This might be
Table 1 Plan information
VMAT IMRT with MR-linac p
Monitor unit (MU) 4173 ± 439 8373 ± 1582 < 0.001
Calculated beam on time (min) 4.8 ± 1.0 18.4 ± 2.2 < 0.001
Number of fields 2 ± 0 8 ± 1 < 0.001
Number of segments N/A 54 ± 7 –
Note: VMAT volumetric modulated arc therapy, IMRT intensity modulated radiation therapy, MR-linac magnetic resonance image linear accelerator
Table 2 Dose-volumetric parameters of the PTV
DV parameter VMAT IMRT with MR-linac p
D98% (Gy) 59.1 ± 0.3 60.3 ± 1.1 < 0.001
D95% (Gy) 60.0 ± 0.0 60.7 ± 1.2 0.015
D5% (Gy) 64.9 ± 1.3 63.8 ± 1.6 0.026
D2% (Gy) 65.3 ± 1.4 64.2 ± 1.7 0.035
Minimum dose (Gy) 54.6 ± 1.4 58.7 ± 1.3 < 0.001
Maximum dose (Gy) 66.8 ± 1.3 63.8 ± 1.5 < 0.001
Mean dose (Gy) 63.0 ± 0.8 62.3 ± 1.4 0.047
PTV volume (cm3) 27.2 ± 23.5 (ITV + 5 mm) 6.3 ± 7.7 (GTV + 3mm) < 0.001
Homogeneity index 0.099 ± 0.023 0.062 ± 0.014 < 0.001
Note: DV parameter dose-volumetric parameter, VMAT volumetric modulated arc therapy, IMRT intensity modulated radiation therapy, MR-linac magnetic
resonance image linear accelerator, Dn% dose received by at least n% volume of the planning target volume, PTV planning target volume, ITV internal target
volume, GTV gross tumor volume
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attributed to the different characteristics of the IMRT and
VMAT technique as well as the different beam arrange-
ments of their plans, as described in the present study [13,
14]. For D1500cc and D1000cc of the ipsilateral lung, the
average differences between MRI-based IMRT and VMAT
were less than only 0.15 Gy, which is insignificant. For the
contralateral lung, VMAT used half arcs proximal to the
ipsilateral lung, and therefore no beams were delivered
through the contralateral lung. In contrast, for MRI-based
IMRT plans, beams were occasionally delivered to the tar-
get volume through the contralateral lung to acquire the
acceptable target conformity, as shown in Fig. 1 (b). This
resulted in relatively higher dose-volumetric parameters of
the contralateral lung in the MRI-based IMRT plans than
in the VMAT plans. In the case of skin, because the
VMAT technique delivers beams through arcs, i.e., nu-
merous beams in various directions are utilized, the doses
can be distributed all over the skin but not concentrated
within specific regions [13]. This can reduce the max-
imum doses to the skin for VMAT plans. In the case of
the spinal cord, because MRI-based IMRT occasionally
uses a beam through the spinal cord according to the tar-
get volume location, as shown in Fig. 1 (d), this could in-
crease the maximum dose to the spinal cord.
Fig. 1 Representative patient dose distributions of volumetric modulated arc therapy and magnetic resonance image-based intensity modulated radiation
therapy. Dose distributions in the axial, coronal, and sagittal planes of volumetric modulated arc therapy (VMAT) of representative patients, namely, patients
A (a) and B (c), are shown. Those of magnetic resonance image-based intensity modulated radiation therapy (MRI-based IMRT) using a linear accelerator
with a magnetic resonance imaging system are shown for patients A (b) and B (d). The planning target volume of VMAT were generated by adding an
isotropic margin of 5mm from the internal target volume, whereas those of MRI-based IMRT were generated by adding an isotropic margin of 3mm from
the gross tumor volume
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The required MUs and beam-on times of MRI-based
IMRT were much larger than those of VMAT. According
to a simple calculation, a beam-on time of approximately
4-times longer on average was required for MRI-based
IMRT as compared to VMAT, which increases the patient
discomfort. In addition, the respiratory gated beam delivery
of MRI-based IMRT would increase the treatment time.
However, the patient setup of MRI-based IMRT is relatively
simpler than that of VMAT for lung SABR because rigor-
ous immobilization devices used to suppress the respiratory
motion of the patient to reduce the ITV margins are not
necessarily applied to a patient in the case of MRI-based
IMRT. This simple setup could increase the degree of
patient comfort. Therefore, MRI-based IMRT has both ad-
vantages and disadvantages in terms of patient comfort. Be-
sides the patient comfort issue, for the long beam-on time
of MRI-based IMRT, there might be a concern regarding
an inaccurate treatment when the treatment time is long.
However, a previous study reported that a long treatment
time is not correlated with an inaccurate treatment for lung
SABR [15]. Moreover, because the treatment beams of
MRI-based IMRT are delivered to patients when monitor-
ing their internal anatomy motion in real time, the long
treatment time of MRI-based IMRT will not hamper the
treatment accuracy.
Several studies comparing MRI-based IMRT using the
ViewRay system to linac-based IMRT or VMAT for lung
SABR have reported that the former are clinically accept-
able but generally worse than those of linac-based IMRT
or VMAT [2, 3, 8–11]. However, no studies have yet been
conducted to compare MRI-based IMRT plans using the
MRIdian Linac system to VMAT plans for lung SABR. In
Fig. 2 Representative dose-volume histograms of the target volume and organs at risk of volumetric modulated arc therapy and magnetic resonance
image-based intensity modulated radiation therapy plans. Dose volume histograms of the planning target volume, both lungs, and whole body from the
volumetric modulated arc therapy and magnetic resonance image-based intensity modulated radiation therapy plans of representative patients, namely,
patients A (a) and B (c) are shown. Those of organs at risk of patients A (b) and B (d) are also shown
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the present study, we conducted a planning study compar-
ing MRI-based IMRT plans using the MRIdian Linac sys-
tem to VMAT plans for lung SABR when the tumors were
located in the lower lob. We presented that the MRI-based
IMRT could reduce doses to bronchi, rib, ipsilateral lung,
and whole body compared to VMAT and this was attrib-
uted to the combination of 6 MV FFF photon beams
generated from the MR-linac, a double-stacked and
double-focus MLC system with small leaf widths, and the
margin reduction capability using a real-time anatomy-
based gating technique.
Conclusions
In the present study, we identified the MRI-based IMRT
with the MRIdian Linac system could improve the dose
homogeneity inside the target volume as well as reduce
doses to bronchi, rib, ipsilateral lung, and whole body
compared to VMAT for lung SABR when the tumors were
located in the lower lobe. In addition, MRI-based IMRT
with the MRIdian Linac system is capable of internal
anatomy-based gated radiotherapy by monitoring real-
time tumor motion, which guarantees an accurate treat-
ment, but currently cannot be conducted using the VMAT
technique. Therefore, it seems appropriate to utilize MRI-
based IMRT for lung SABR when the tumors were located
in the lower lobe.
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Table 3 Dose-volumetric parameters of OARs and whole body
OAR DV parameter VMAT IMRT with MR-linac p
Bronchi Maximum dose (Gy) 24.2 ± 21.7 20.4 ± 19.0 < 0.001
V34.8Gy (cm
3) 0.5 ± 2.0 0.0 ± 0.1 0.223
Esophagus V30Gy (cm
3) 0.0 ± 0.0 0.0 ± 0.0 –
Heart Maximum dose (Gy) 20.2 ± 16.0 19.1 ± 13.7 0.087
V34Gy (cm
3) 0.7 ± 2.4 0.0 ± 0.1 0.168
Ipsilateral lung Mean dose (Gy) 5.7 ± 2.0 5.2 ± 2.1 0.041
V20Gy (cm
3) 134.8 ± 81.4 116.8 ± 80.9 0.025
V10Gy (cm
3) 275.3 ± 139.3 244.7 ± 140.2 0.047
V5Gy (cm
3) 414.7 ± 182.0 358.1 ± 172.9 < 0.001
D1500cc (Gy) 0.13 ± 0.25 0.24 ± 0.37 0.001
D1000cc (Gy) 0.61 ± 1.15 0.76 ± 0.94 0.012
Contralateral lung Mean dose (Gy) 0.9 ± 0.4 1.0 ± 0.6 0.210
V20Gy (cm
3) 0.0 ± 0.0 6.6 ± 20.1 0.146
V10Gy (cm
3) 0.5 ± 1.6 23.1 ± 44.3 0.029
V5Gy (cm
3) 23.4 ± 37.1 49.8 ± 72.1 0.049
D1500cc (Gy) 0.06 ± 0.10 0.11 ± 0.14 0.002
D1000cc (Gy) 0.21 ± 0.28 0.28 ± 0.17 0.046
Rib Maximum dose (Gy) 47.2 ± 16.5 43.0 ± 12.9 0.032
V40Gy (cm
3) 7.7 ± 13.0 1.8 ± 3.9 0.008
Skin Maximum dose (Gy) 27.8 ± 9.4 33.0 ± 4.4 0.018
V36Gy (cm
3) 0.1 ± 0.4 0.1 ± 0.2 0.167
Spinal cord Maximum dose (Gy) 11.0 ± 5.1 14.5 ± 5.6 0.002
V26Gy (cm
3) 0.0 ± 0.0 0.0 ± 0.0 –
Whole body Mean dose (Gy) 1.2 ± 0.5 0.9 ± 0.3 < 0.001
V50% (cm
3) 103.5 ± 82.8 78.7 ± 62.9 < 0.001
Note: OAR organ at risk, DV parameter dose-volumetric parameter, VMAT volumetric modulated arc therapy, IMRT intensity modulated radiation therapy, MR-linac
magnetic resonance image linear accelerator, VnGy percent volume receiving n Gy, Dncc dose received by at least n cc volume of the planning target volume, Vn%
percent volume receiving n% of the prescription dose
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